12615 Results

People

  1. Ladanyi
    Ladanyi
  2. Reuter
    Reuter
  3. Antonescu
    Antonescu
  4. Berger
    Berger
  5. Travis
    Travis
  6. Shia
    Shia
  7. Busam
    Busam
  8. Al-Ahmadie
    Al-Ahmadie
  9. Arcila
    Arcila
  10. Weigelt
    Weigelt

Groups

  1. Department of Pathology and Laboratory Medicine (12615)
  2. GSK Faculty (4773)
  3. Department of Medicine (4722)
  4. Surgery (3639)
  5. Solid Tumor Oncology Division (3422)
  6. Human Oncology and Pathogenesis Program (3037)
  7. Tow Center for Developmental Oncology (TCDO) (2643)
  8. Sloan Kettering Institute Postdocs (2500)
  9. Survivorship Research (2113)
  10. Epidemiology and Biostatistics (2024)
  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (6438)
  2. Meeting Abstract (5172)
  3. Review (332)
  4. Book Section (310)
  5. Editorial (92)
  6. Research Letter (73)
  7. Guidelines (52)
  8. Correspondence (47)
  9. Conference Paper (38)
  10. Miscellaneous (37)
  11. Book Whole (24)
Groups
  1. Department of Pathology and Laboratory Medicine (12615)
  2. GSK Faculty (4773)
  3. Department of Medicine (4722)
  4. Surgery (3639)
  5. Solid Tumor Oncology Division (3422)
  6. Human Oncology and Pathogenesis Program (3037)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Victor Reuter (1228)
  3. Cristina Antonescu (895)
  4. Michael Berger (765)
  5. William Travis (743)
  6. Jinru Shia (719)

More People

Years
  1. 2025 (307)
  2. 2024 (719)
  3. 2023 (766)
  4. 2022 (841)
  5. 2021 (677)
  6. 2020 (787)

More Years

Publications
  1. Laboratory Investigation (1448)
  2. Modern Pathology (1440)
  3. Journal of Clinical Oncology (863)
  4. American Journal of Surgical Pathology (429)
  5. Cancer Research (426)
  6. Blood (349)

More Publications

Publishers
  1. Nature Publishing Group (1939)
  2. Nature Research (1457)
  3. Elsevier Inc. (1139)
  4. American Society of Clinical Oncology (955)
  5. American Association for Cancer Research (923)
  6. Lippincott Williams & Wilkins (896)

More Publishers

Results (12615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association of KRAS mutation with worse recurrence-free survival and site of metastatic progression after resection of hepatic colorectal metastases
    Meeting Abstract

    Kemeny, N. E.; Chou, J. F.; Capanu, M.; Gewirtz, A. N.; Cercek, A.; Kingham, T. P.; Jarnagin, W. R.; Fong, Y.; DeMatteo, R. P.; Allen, P. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Variable penetrance of CDH1 mutation diffuse gastric cancer: A genomic analysis
    Meeting Abstract

    Kelsen, D. P.; Schrader, K. A.; Khanin, R.; Tang, L. H.; Salo-Mullen, E. E.; Offit, K.; Joseph, V.; Viale, A.; Mirander, M.; Coit, D. G.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A multicenter effort to identify driver mutations and employ targeted therapy in patients with lung adenocarcinomas: The Lung Cancer Mutation Consortium (LCMC)
    Meeting Abstract

    Johnson, B. E.; Kris, M. G.; Berry, L. D.; Kwiatkowski, D. J.; Iafrate, A. J.; Varella-Garcia, M.; Wistuba, I. I.; Franklin, W. A.; Ladanyi, M.; Su, P. F.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab-refractory esophagogastric (EG) cancer
    Meeting Abstract

    Janjigian, Y. Y.; Capanu, M.; Gromisch, C. M.; Kelsen, D. P.; Ku, G. Y.; Brown, K. T.; Schattner, M.; Ilson, D. H.; Solit, D. B.; Berger, M. F.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Vemurafenib (VEM) in patients (pts) with BRAF-mutant melanoma and brain metastases (mets)
    Meeting Abstract

    Harding, J. J.; Catalanotti, F.; Yaqubie, A.; McDermott, G. C.; Kersellius, R.; Merghoub, T.; Carvajal, R. D.; D'Angelo, S. P.; Dickson, M. A.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A retrospective analysis of the prevalence of EGFR or KRAS mutations in patients (pts) with crizotinib-naive and crizotinib-resistant, ALK-positive non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Gainor, J. F.; Varghese, A. M.; Ou, S. H. I.; Kabraji, S.; Awad, M. M.; Katayama, R.; Pawlak, A.; Mino-Kenudson, M.; Yeap, B. Y.; Riely, G. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase I study of weekly albumin-bound paclitaxel (ab-P) plus weekly cetuximab (Cet) plus intensity-modulated radiation therapy (IMRT) in patients with stage III/IVb head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Rao, S. S.; Wolden, S. L.; Smith-Marrone, S.; Ng, K. K.; Mueller, B.; Gelblum, D. Y.; Dutta, P. R.; Lee, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Screening for RET and ROS1 fusions in an enriched cohort of pan-negative never-smokers with advanced lung adenocarcinomas to identify patients for treatment in targeted therapy trials
    Meeting Abstract

    Drilon, A. E. D.; Wang, L.; Hasanovic, A.; Joubert, P.; Kris, M. G.; Riely, G. J.; Ladanyi, M.; Rizvi, N. A.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A pilot study of preoperative, single-dose ipilimumab (Ipi) and/or cryoablation (Cryo) in women (pts) with early stage/resectable breast cancer (ESBC)
    Meeting Abstract

    Diab, A.; Solomon, S. B.; Sacchini, V.; Comstock, C.; Maybody, M.; Durack, J. C.; Sung, J. S.; Blum, B.; Neville, D. A.; Kotin, A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Detection of the NRAS Q61R mutation in Erdheim-Chester disease
    Meeting Abstract

    Diamond, E. L.; Pentsova, E.; Borsu, L.; Chiu, A. E.; Hyman, D. M.; Rosenblum, M.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save